Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2023-02-05 Regulatory Filings
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Psilocybin and MDMA down-scheduled 3 pages 299.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 6 February 2023 from Little Green Pharma regarding the Therapeutic Goods Administration's (TGA) decision to down-schedule psilocybin and MDMA. It discusses regulatory changes, clinical trial plans, and strategic implications for the company and its subsidiary Reset Mind Sciences. The content is primarily an announcement of regulatory and strategic developments rather than a financial report or detailed financial data. The document length is 8054 characters, which is moderate, but the content is clearly an announcement rather than a full report or presentation. There are no financial statements, earnings data, or detailed management analysis. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is not a voting result, director dealing, or capital change. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a significant regulatory decision affecting the company and its operations, which does not fit into more specific categories.
2023-02-05 English
Amended Constitution 59 pages 867.3KB
Governance Information Classification · 100% confidence The document is an ASX announcement dated 2 February 2023 regarding the amended constitution of Little Green Pharma Ltd. It includes the full text of the company's constitution, detailing definitions, share capital, directors' powers, meetings, dividends, and other governance-related provisions. The document is lengthy (15,000 characters) and contains the actual constitution text, not just an announcement or a link to it. The content focuses on the company's internal rules, board structure, and governance practices, which aligns with the Governance Information category. It is not a financial report, earnings release, or management discussion, nor is it a proxy statement or voting result. Therefore, the appropriate classification is Governance Information (CGR).
2023-02-01 English
Results of Meeting 3 pages 175.5KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 31 January 2023 providing detailed results of a general meeting of shareholders. It includes voting outcomes on various resolutions, including ratifications, approvals of plans, and issuance of shares/options to directors and employees. The content focuses exclusively on the official results of shareholder votes at a general meeting. There is no indication of it being a full report, financial statement, or presentation. The document matches the description of 'Declaration of Voting Results & Voting Rights Announcements' which covers official results from shareholder votes at any general meeting. The document length (5712 characters) is sufficient to contain detailed voting results, not just a brief announcement or link to a report. Therefore, the correct classification is DVA.
2023-01-30 English
Application for quotation of securities - LGP 6 pages 27.6KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX by Little Green Pharma Ltd. It details the number and type of securities to be quoted, references previous announcements (Appendix 3B), and provides information about issued capital following the quotation. There are no financial statements, earnings data, or management discussion. The document is a formal announcement related to capital market activities, specifically the quotation of securities, which aligns with announcements about share issues or capital changes. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief notice but a detailed application, supporting a high confidence classification.
2023-01-18 English
Results of Share Purchase Plan 2 pages 164.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 19 January 2023 regarding the results of a Share Purchase Plan (SPP). It details the amount raised, number of shares issued, issue price, and the issuance date of shares and options. The content focuses on fundraising and capital structure changes through a share issuance. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The document is not a regulatory certification or a voting result announcement. Given the focus on fundraising and share issuance, the appropriate classification is Capital/Financing Update (CAP). The document length is 3378 characters, which is consistent with an announcement rather than a full report.
2023-01-18 English
Notification regarding unquoted securities - LGP 7 pages 30.9KB
Capital/Financing Update Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities, specifically options issued by Little Green Pharma Ltd. It details the number of securities issued, their terms, and compliance with ASX listing rules. The content focuses on the issuance of new securities and capital raising activities, without containing financial statements or earnings data. This fits the category of a Capital/Financing Update, as it reports on new securities issued and capital structure changes.
2023-01-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.